Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients With Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC

The Diabetes Control and Complications Trial (DCCT) demonstrated that a mean of 6.5 years of intensive therapy aimed at near-normal glucose levels reduced the risk of development and progression of retinopathy by as much as 76% compared with conventional therapy. The Epidemiology of Diabetes Interve...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2015
Materias:
Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303965/
https://www.ncbi.nlm.nih.gov/pubmed/25204977
http://dx.doi.org/10.2337/db14-0930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303965/
https://www.ncbi.nlm.nih.gov/pubmed/25204977
http://dx.doi.org/10.2337/db14-0930

Ejemplares similares